Treatment of Resistant Metastatic Melanoma Using Decitabine, Temozolomide and Panobinostat
Clinical trial NCT00925132 · TERMINATED
Trial details
- NCT number
- NCT00925132
- Sponsor
- University of Iowa
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2014-11-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.